MARZOLA, Erika
 Distribuzione geografica
Continente #
NA - Nord America 3.307
EU - Europa 1.116
AS - Asia 819
SA - Sud America 74
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.325
Nazione #
US - Stati Uniti d'America 3.289
SG - Singapore 386
IT - Italia 335
CN - Cina 245
DE - Germania 160
UA - Ucraina 154
PL - Polonia 133
GB - Regno Unito 108
TR - Turchia 100
FI - Finlandia 70
BR - Brasile 57
SE - Svezia 50
ID - Indonesia 31
BE - Belgio 27
NL - Olanda 19
FR - Francia 18
CA - Canada 15
HK - Hong Kong 13
LT - Lituania 10
IR - Iran 9
CO - Colombia 8
IN - India 7
AT - Austria 6
RU - Federazione Russa 6
VN - Vietnam 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
IL - Israele 4
PE - Perù 4
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BG - Bulgaria 2
IQ - Iraq 2
JP - Giappone 2
MX - Messico 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
UY - Uruguay 2
UZ - Uzbekistan 2
AR - Argentina 1
AZ - Azerbaigian 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
GE - Georgia 1
HU - Ungheria 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
TH - Thailandia 1
Totale 5.325
Città #
Fairfield 423
Woodbridge 404
Ann Arbor 238
Ashburn 214
Houston 212
Singapore 203
Seattle 181
Santa Clara 180
Jacksonville 168
Chandler 166
Ferrara 153
Cambridge 149
Wilmington 147
Warsaw 132
New York 62
Izmir 59
Milan 56
Princeton 52
Dearborn 47
Nanjing 46
Addison 44
Beijing 44
Helsinki 39
Shanghai 39
San Diego 36
Jakarta 31
Boardman 30
Brussels 25
Los Angeles 25
Auburn Hills 16
Munich 16
Redwood City 16
London 15
Falkenstein 14
Nanchang 14
Hong Kong 13
Bremen 12
San Mateo 12
Ferrara di Monte Baldo 11
Shenyang 11
Changsha 10
Hebei 10
Mountain View 10
Bologna 9
Turin 9
Jinan 8
Toronto 8
Jiaxing 7
Medellín 7
Ningbo 7
Norwalk 7
Padova 7
Philadelphia 7
Tappahannock 7
Washington 7
Augusta 6
Frankfurt am Main 6
Zhengzhou 6
Dong Ket 5
Dublin 5
Falls Church 5
Istanbul 5
Kunming 5
Nuremberg 5
Jena 4
Leawood 4
Lima 4
Parma 4
São Paulo 4
Tianjin 4
Brescia 3
Des Moines 3
Florence 3
Grassano 3
Indiana 3
Lanzhou 3
Olomouc 3
Ottawa 3
Prescot 3
Taizhou 3
Assago 2
Baghdad 2
Belo Horizonte 2
Bragança Paulista 2
Brno 2
Catania 2
Charlottesville 2
Chiswick 2
Council Bluffs 2
Guangzhou 2
Haikou 2
Hohenhameln 2
Imola 2
Jeddah 2
Jerusalem 2
Lauterbourg 2
Manchester 2
Monmouth Junction 2
Montechiarugolo 2
Montevideo 2
Totale 4.017
Nome #
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 198
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 191
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 177
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 162
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 158
Physicochemical stability of cabazitaxel and docetaxel solutions 155
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 153
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 151
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 148
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 148
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 145
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 145
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 142
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 136
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 133
Pharmacological characterization of tachykinin tetrabranched derivatives 127
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 124
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 124
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 122
Structure-activity study at positions 3 and 4 of human neuropeptide S. 121
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 120
Synthesis and antimicrobial activity of dermaseptin S1 analogues 118
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 115
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 115
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 109
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 109
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human Prion protein 107
Structure-activity relationship study on human urotensin II 106
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 105
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 96
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 96
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 95
null 94
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 91
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 89
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 89
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 76
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 69
Novel Mixed NOP/Opioid Receptor Peptide Agonists 58
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 57
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 56
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 52
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 51
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 50
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 48
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 46
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 44
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 43
null 42
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 41
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 28
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 26
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 19
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 16
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 16
Totale 5.452
Categoria #
all - tutte 29.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 372
Totale 30.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 0 0 0 0 0 67 40 29
2020/2021729 42 53 43 82 37 67 79 83 36 71 95 41
2021/2022595 28 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/20251.030 35 29 146 62 175 142 28 71 255 87 0 0
Totale 5.452